Technology Commercialization Group (TCG)
TCG is a life sciences consulting firm with offices in the US and Europe (http://tcgmedtech.com). Founded in 1998, TCG serves life science companies from its headquarters in the Research Triangle Park region of North Carolina, USA and offices in Heidelberg, Germany.
We lead and advise transactions, including licensing, strategic partnerships, distribution agreements, asset sales, acquisitions, and more. We provide interim management, when you need an experienced executive to lead a critical project, enter a new market, develop a new strategy, refocus a company, and more.
Life science companies are built upon successful strategic relationships and transactions. The key to a successful transaction is identifying realistic objectives, locating the right partners, structuring a deal that meets the needs of both parties, and managing the negotiations to reach a successful outcome.
TCG can help. With our years of experience and large network of international contacts, we can lead and advise:
- In-licensing and out-licensing
- Development/Commercialization partnerships
- Mergers and Acquisitions
- Process-driven asset sales
- Private equity or debt financing*
*TCG provides these services through its affiliation with Daybreak Capital Partners, a New York-based specialty investment banking firm.
Jim has spent over 30 years in early-stage medical device, diagnostic, and healthcare service companies with experience in general management, finance, M&A/licensing, and product development strategy. He has been a partner of TCG since 2008 and has served clients in several areas.
For 30+ years, Ken West has successfully led the growth of life science companies in a wide array of markets including medical device, specialty materials, veterinary services, and information technology.
TCG's Strategic Partners working with NCI